Diagnostic and Management Strategies for Invasive Aspergillosis
NCT00816088 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 203
Last updated 2014-12-23
Summary
Fungal infections caused by Aspergillus fumigatus are now identified in up to 45% of patients dying from haematological malignancy. There has been a significant increase in deaths from IA over the last 20 years. Our current diagnostic approach is neither sensitive nor specific. The purpose of this study is to prospectively assess the value of current diagnostic tools, as well as test other new diagnostic methods for the diagnosis of IA among haemato-oncology patients undergoing chemotherapy or stem cell transplantation.
Conditions
- Invasive Aspergillosis
- Neutropenia
Sponsors & Collaborators
-
King's College Hospital NHS Trust
lead OTHER
Principal Investigators
-
M.Mansour Ceesay, FRCPath · Kings College Hospital
-
Antonio Pagliuca, FRCPath · Kings College Hospital
-
Jim Wade, FRCPath · Kings College Hospital
-
Melvyn Smith, PhD · Kings College Hospital
-
Sujal Desai, FRCR · Kings College Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-12-31
- Primary Completion
- 2011-12-31
- Completion
- 2011-12-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Early Molecular Detection for the Improved Diagnosis of Invasive Pulmonary Aspergillosis and Invasive Pulmonary Zygomycosis
NCT00923832 ·Status: COMPLETED
-
Identification of Serum and/or Plasma Biomarkers for the Diagnosis Prognosis and/or Prediction of Invasive Mycosis in Neutropenic Patients
NCT01907477 ·Status: COMPLETED ·Phase: NA
-
Clinical Implications of Azole-Resistant Aspergillosis in Hematological Malignancy
NCT03221075 ·Status: COMPLETED
-
Diagnostic Performance of an Aspergillus-specific Nested PCR Assay in Cerebrospinal Fluid Samples
NCT01614145 ·Status: UNKNOWN
-
Early Diagnosis of Invasive Lung Aspergillosis
NCT05860387 ·Status: RECRUITING
-
Natural History Study of Fungal Infections of the Blood in Patients With Cancer or in Patients Who Have Undergone a Stem Cell Transplant
NCT00445952 ·Status: COMPLETED
-
Aspergillus-specific PCR Assay in Cerebrospinal Fluid Samples for Detection of Central Nervous System Aspergillosis
NCT01617759 ·Status: UNKNOWN
-
Study of FK463 for the Treatment of Invasive Aspergillosis
NCT00036166 ·Status: COMPLETED ·Phase: PHASE2
-
Role of Antifungal Prophylaxis in Elderly Patients With Acute Myeloid Leukemia During Consolidation Therapy
NCT06382922 ·Status: RECRUITING
-
Prophylaxis of Fungal Invasive Infections in Leukemia
NCT00501098 ·Status: COMPLETED ·Phase: PHASE2
-
Prospective Multicenter Evaluation of the MycoGenie Kit for the Diagnosis of Invasive Aspergillosis
NCT03349931 ·Status: COMPLETED
-
Voriconazole vs. Amphotericin B in the Treatment of Invasive Aspergillosis
NCT00001646 ·Status: COMPLETED ·Phase: PHASE3
-
Efflux Pump Mediated Azole Resistance in Candida Albicans
NCT03659162 ·Status: UNKNOWN
-
Prevalence of Influenza RelAted Invasive Aspergillosis
NCT04172610 ·Status: COMPLETED
-
PCR for Aspergillus Fumigatus in Blood and Bronchoalveolar Lavage Fluid for Monitoring Cases of Invasive Aspergillosis: What is Its Prognostic Value
NCT07313527 ·Status: RECRUITING
-
King's Invasive Aspergillosis Study II
NCT02875743 ·Status: COMPLETED ·Phase: PHASE4
-
Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant
NCT00110045 ·Status: COMPLETED ·Phase: PHASE2
-
Aspergillosis and Humoral Alveolar Immunity by Proteomics
NCT04728763 ·Status: UNKNOWN
-
Empirical Versus Preemptive Antifungal Therapy
NCT01288378 ·Status: COMPLETED ·Phase: PHASE3
-
Diagnostic Study of Combined Biomnarker Testing in Bronchoalveolar Lavage Samples of Immunocompromised Patients
NCT01695512 ·Status: UNKNOWN
-
Galactomannan Antigen in Bronchoalveolar Lavage in the Diagnosis of Invasive Aspergillosis in Neutropenic Patients
NCT01128907 ·Status: COMPLETED
-
A Comparison of Fluconazole and Amphotericin B in the Treatment of Fungal Infections
NCT00002277 ·Status: COMPLETED ·Phase: PHASE3
-
MK0991 in Combination With Standard Antifungal Agent(s) for the Treatment of Salvage Invasive Aspergillosis (0991-037)
NCT00076869 ·Status: COMPLETED ·Phase: PHASE2
-
Fungemia in Hematologic Malignancies
NCT02451592 ·Status: COMPLETED
-
ManagemEnt of Antifungal Drug in Invasive Aspergillosis:a Real-word Study
NCT06028451 ·Status: RECRUITING